Skip to main content
. 2018 Mar 27;11:197. doi: 10.1186/s13104-018-3302-0

Fig. 1.

Fig. 1

Synergistic anti-proliferative effects of ABT-263 and A-1210477 in the cervical cancer cells at 1:1 drug concentration ratios. a SiHa b CaSki and c C33A cell line was treated with increasing concentrations of ABT-263 (0–32 µM) (diamond) or A-1210477 (0–32 µM) (triangle) or combination of ABT-263 and A-1210477 (circle) at 1:1 drug concentration ratios for 72 h. Cell proliferation was assessed using the SyBr Green I assay. Points represent ± SEM of four repeats